Mirae Asset Global Investments
RCUS icon

Mirae Asset Global Investments’s Arcus Biosciences RCUS Stock Holding History

Mirae Asset Global Investments’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,356
Closed -$583K – 2301
2024
Q1 		$583K Buy
32,356
+1,702
+6% +$29.4K ﹤0.01% 1832
2023
Q4 		$585K Sell
30,654
-855
-3% -$13.7K ﹤0.01% 1887
2023
Q3 		$566K Sell
31,509
-849
-3% -$17.1K ﹤0.01% 1822
2023
Q2 		$651K Sell
32,358
-5,308
-14% -$101K ﹤0.01% 1824
2023
Q1 		$687K Buy
37,666
+15,572
+70% +$298K ﹤0.01% 1756
2022
Q4 		$457K Buy
22,094
+551
+3% +$15.2K ﹤0.01% 1942
2022
Q3 		$564K Buy
21,543
+7,971
+59% +$211K ﹤0.01% 1802
2022
Q2 		$344K Sell
13,572
-16,181
-54% -$396K ﹤0.01% 1922
2022
Q1 		$939K Buy
+29,753
New +$997K ﹤0.01% 1345

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mirae Asset Global Investments's RCUS Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Arcus Biosciences (RCUS) in Q2 2024, closing a stake of 32,356 shares — an estimated $583K sold.

Mirae Asset Global Investments first reported a position in RCUS in Q1 2022 and held it in 9 quarters. The position peaked at $939K in Q1 2022. 193 funds tracked by Wall St. Rank hold RCUS as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Arcus Biosciences position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 32,356 Arcus Biosciences shares in Q2 2024, an estimated $583K.
  • Mirae Asset Global Investments first reported a position in Arcus Biosciences in Q1 2022 and held it in 9 quarters.
  • Mirae Asset Global Investments's Arcus Biosciences position peaked at $939K in Q1 2022.
  • 193 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.